Your browser doesn't support javascript.
loading
[Precision oncology from a proteogenomics perspective].
Huang, Yurou; Wu, Songfeng; Shu, Kunxian; Zhu, Yunping.
Afiliação
  • Huang Y; School of Bioinformatics, Chongqing University of Posts and Telecommunications, Chongqing 400065, China.
  • Wu S; National Center for Protein Sciences (Beijing), Beijing Institute of Life Omics, Academy of Military Medical Sciences, Academy of Military Sciences, Beijing 102206, China.
  • Shu K; Proteome Research Center, Beijing 102206, China.
  • Zhu Y; National Center for Protein Sciences (Beijing), Beijing Institute of Life Omics, Academy of Military Medical Sciences, Academy of Military Sciences, Beijing 102206, China.
Sheng Wu Gong Cheng Xue Bao ; 38(10): 3616-3627, 2022 Oct 25.
Article em Zh | MEDLINE | ID: mdl-36305397
ABSTRACT
Cancer is a heterogeneous disease with complex mechanisms that requires targeted precision medicine strategies. The growth of precision medicine is indispensable from the rapid development of genomics. However, genomics has certain limitations in molecular phenotype analysis, proteogenomics thus arose at the right time. Proteogenomics is the merging of proteomics and genomics. This review describes the limitations of genomic analysis and highlights the importance of proteogenomics to re-understand precision oncology from a proteogenomic perspective. In addition, the application of proteogenomics in precision oncology is briefly introduced, the related public data projects are described, and finally, the challenges that need to be addressed at this stage are proposed.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteogenômica / Neoplasias Limite: Humans Idioma: Zh Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteogenômica / Neoplasias Limite: Humans Idioma: Zh Ano de publicação: 2022 Tipo de documento: Article